Comparative Short-Term Efficacy of Combined Ozone and Platelet-Rich Plasma versus Concentrated Growth Factor in the Treatment of Knee Osteoarthritis
Open Access
- 10 January 2026
- journal article
- Published by AVES YAYINCILIK A.Ş. in The Eurasian Journal of Medicine
- Vol. 58 (1) , 1-7
Abstract
Background: Knee osteoarthritis (KOA) is a prevalent degenerative joint disease causing pain and functional impairment. Emerging regenerative therapies, including platelet-rich plasma (PRP) and concentrated growth factor (CGF), have shown promise in managing KOA. This study evaluates the short-term efficacy of combined ozone-PRP therapy versus CGF injections in patients with mild to moderate KOA. Methods: This retrospective, cross-sectional study analyzed data from 49 patients (94 knees) treated with either ozone-PRP (26 patients, 50 knees) or CGF (23 patients, 44 knees) injections. Pain and function were assessed using the Visual Analogue Scale (VAS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) before and 1 month after treatment. Results: Both groups demonstrated significant improvements in VAS and WOMAC scores posttreatment (P < .001). However, inter-group comparisons revealed no statistically significant differences in pain reduction or functional improvement (P > .05). In the CGF group, greater pain reduction was observed compared to ozone-PRP (P = .028), while no between-group differences were found in WOMAC pain, stiffness, function, or total scores (P = .298, P = .066, P = .110, and P = .077, respectively). Conclusion: Both ozone-PRP and CGF injections are effective in reducing pain and improving function in patients with mild to moderate knee osteoarthritis in the short term; however, although CGF provides greater pain reduction, the overall WOMAC outcomes are comparable, and the 2 methods may be used interchangeably based on their respective advantages and clinical considerations. Cite this article as: Ayık B, Sarı.imen G, Bakılan F, Armağan O. Comparative Short-Term Efficacy of Combined Ozone and Platelet-Rich Plasma versus Concentrated Growth Factor in the Treatment of Knee Osteoarthritis. The Eurasian Journal of Medicine 2026, 58(1), 0967, doi: 10.5152/eurasianjmed.2026.25967.Keywords
This publication has 30 references indexed in Scilit:
- Intra‐articular injections of platelet‐rich plasma in symptomatic knee osteoarthritis: a consensus statement from French‐speaking expertsKnee Surgery, Sports Traumatology, Arthroscopy, 2020
- 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and KneeArthritis Care & Research, 2020
- Oxygen–Ozone Therapy for the Treatment of Knee Osteoarthritis: A Systematic Review of Randomized Controlled TrialsArthroscopy, 2019
- Choice of intra-articular injection in treatment of knee osteoarthritis: platelet-rich plasma, hyaluronic acid or ozone optionsKnee Surgery, Sports Traumatology, Arthroscopy, 2016
- Platelet-rich plasma and its derivatives as promising bioactive materials for regenerative medicine: basic principles and concepts underlying recent advancesOdontology, 2015
- Comparative Effectiveness of Platelet-Rich Plasma Injections for Treating Knee Joint Cartilage Degenerative Pathology: A Systematic Review and Meta-AnalysisArchives of Physical Medicine and Rehabilitation, 2014
- Bone tissue engineering with bone marrow-derived stromal cells integrated with concentrated growth factor in Rattus norvegicus calvaria defect modelJournal of Artificial Organs, 2013
- The prevalences of some rheumatic diseases in western Turkey: Havsa studyRheumatology International, 2011
- Epidemiology of OsteoarthritisClinics in Geriatric Medicine, 2010
- Validity, reliability, and comparison of the WOMAC osteoarthritis index and Lequesne algofunctional index in Turkish patients with hip or knee osteoarthritisClinical Rheumatology, 2010